DFTX compared with NAGE: revenue, margins and what each company keeps, and the suppliers and customers both name

DFTXDefinium Therapeutics, Inc.

Mkt capRevenueRevenue

NAGENiagen Bioscience, Inc.

Mkt capRevenueRevenue

Compare

DFTXDefinium Therapeutics, Inc.

NAGENiagen Bioscience, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only DFTX 0

None

Shared 0

No disclosed counterparties: DFTX.

Only NAGE 5

—A.S. Watsonunlistedcustomer

AMZNAmazoncustomer

—W.R. Grace & Co.-Connunlistedsupplier

—Queen's University Belfastunlistedsupplier

1 more · NAGE chain ›

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

DFTXDefinium Therapeutics, Inc.

33.27▲+9.57%· post 33.05

Mkt cap$4.5BRevenue—Revenue—

NAGENiagen Bioscience, Inc.

2.07▼−1.90%· post 2.07

ClosedNov 6 '26

Mkt cap$163.9MRevenue$27MQ3 FY26Revenue$129MFY25

Compare

ClosedNov 6 '26

DFTXDefinium Therapeutics, Inc.

NAGENiagen Bioscience, Inc.

33.27▲+9.57%post 33.05

Price

2.07▼−1.90%post 2.07

$4.5B

Mkt cap

$163.9M

—

Revenue

$27MQ3 FY26

—

Revenue

$129MFY25

DFTX33.27▲+9.57%vsNAGE2.07▼−1.90%ClosedNov 6 '26